LEVERAGE LONG - ROCHE GS Share Price

Certificat

RO4LSG

DE000SB37G16

Real-time Bid/Ask 08:33:57 28/05/2024 BST
3.45 CHF / 3.46 CHF +1.62% Intraday chart for LEVERAGE LONG - ROCHE GS
Current month+15.25%
1 month+14.48%
Date Price Change
27/05/24 3.4 -1.16%
24/05/24 3.44 -2.55%
23/05/24 3.53 +1.15%
22/05/24 3.49 -6.68%
21/05/24 3.74 -2.35%

Delayed Quote Swiss Exchange

Last update May 27, 2024 at 04:20 pm

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying ROCHE HOLDING AG
IssuerLogo Issuer Société Générale Société Générale
RO4LSG
ISINDE000SB37G16
Date issued 07/08/2020
Maturity Unlimited
Parity 1 : 1
Emission price- CHF
Emission volume N/A
Settlement cash
Currency CHF

Technical Indicators

Highest since issue 48.7 CHF
Lowest since issue 2.6 CHF
Spread 0.01 CHF
Spread %0.29%

Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Sector
-
More about the company

Ratings for Roche Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
A+
More Ratings

Consensus: Roche Holding AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
229.9 CHF
Average target price
279.8 CHF
Spread / Average Target
+21.72%
Consensus
  1. Stock Market
  2. Certificates
  3. RO4LSG Certificat